Broadly considered, settlement procedures for antitrust breaches in Portugal follow closely the outline of plea-bargaining arrangements existing at EU level. This article reviews the first situation in which the Competition Authority used the settlement proceedings in an antitrust investigation.
The Personal Data Protection Act 2012 (Act) was passed by the Singapore Parliament on 15 October 2012 and came into effect in Singapore on 2 January 2013. A major component of the Act was to put in place general data protection provisions (Data Protection Provisions) that apply to all organisations operating in the private sector in Singapore. Previously, only limited confidentiality obligations existed in Singapore under certain sector specific legislation.
This is a sample non-disclosure agreement in bilateral form.
A brief overview on the Novartis Pharmaceuticals Canada Inc. v. Cobalt Pharmaceuticals Co., 2014 FCA 17 (Novartis) case.
Linking to protected content on a free website does not constitute an unauthorised "communication to the public", according to the decision of the Court of Justice of the European Union (ECJ) (Case C-466/12 Svensson) on 13 February 2014. Read more about this decision in this Ashurst article.
Digital communications and electronically stored data come with inherent vulnerabilities and the potential for employer liability. Harnessing the power of the digital age while controlling workplace risks is a challenge. The notion of electronic communications and social media in the workplace has changed drastically over the past decade, morphing from activities employers often sought to limit to required activities of one’s job in many occupations, including those that will help grow the business. This InfoPAK covers laws impacting privacy and data security and best practices for reducing workplace information risk. It also discusses the particular benefits and risks of the company’s use of social media and social networking technologies. Finally, it looks at the issues in employment litigation arising out of digital information and communications.
Beginning on 1 January 2014, French pharmacists are now legally permitted to substitute a biosimilar for the prescribed (reference) biological medicine as long as the prescribing physician has not marked the prescription as “non-substitutable.” According to the new law, substitution is allowed only when initiating a course of treatment, and if the biosimilar belongs to the same group as the prescribed product, known as a “similar biologic group.” The criteria for inclusion in a “similar biologic group” have yet to be defined by the French healthcare authority (ANSM).
This sample is a checklist for executing releases in Puerto Rico.
Mexico ardently protects the privacy of its individual citizens' personal data and sensitive personal information. This protection is enforced though the Federal Personal Information Protection Law and its regulations. The Federal Institute for Access to Public Information and Protection of Information (IFAI) is the agency in charge of enforcement. This article reviews the eight main principles of this law.
In Mexico, as in the rest of the world, trademarks that are duly registered may be enforced against third parties who attempt to use or copy them. It is advisable to take certain measures with respect to their use and maintenance. This article offers several recommendations, including the following: Always use marks in the manner in which they were registered.